Lau Laboratory
Matt Labenski

Matt Labenski

Current Position:

Research Scientist I, Analytical Pharmacology Group, Avila Therapeutics, Waltham, MA

Education:

  • Ph.D. Pharm/Tox University of Arizona, Tucson, AZ 2003-2008
  • B.S. Toxicology Northeastern University, Boston, MA 2001

Achievements:

  • 1st Place in the Graduate Student Best Paper Competition sponsored by the Divison of Toxicology, American Society of Pharmacology and Experimental Therapeutics, FASEB 2007

Professional Experience:

  • Research Assistant, University of Arizona, Tucson, AZ 2003-2008
  • Research Associate, PRAECIS Pharmaceuticals Inc., Waltham, MA 2001-2003

Research Project:

Hydroquinone is a nephrocarcinogen in male Fischer rats and a potential human carcinogen. It is a metabolite of benzene, used by the chemical industry as an oxidizer, and is found in cigarette smoke. Metabolites of hydroquinone include multiple glutathione additions of up to 4 with 3 being the most toxic to the kidney and are selective for the proximal tubular epithelium. Hydroquinone and its metabolites are all capable of redox cycling and adducting macromolecules within the cell. My project used proteomics to try and determine what proteins Hydroquinone and its metabolites are adducting in cells and in vivo. By using mass spectrometric techniques it is possible to not only identify proteins being adducted, but to also map the adduction site to the specific amino acid. Once these proteins are identified it will be important to determine the structural and functional consequences of these adductions. We utilized both a protein model to determine the structural consequence and activity assays to see if the protein is still functional.

Another aspect of my project was to examine gene dysregulation in the kidney using microarray analysis after chronic treatment of rats with 2,3,5-tris-(glutathion-S-yl)hydroquinone (TGHQ), the most nephrotoxic metabolite of Hydroquinone. This project is meant to further explore the TGHQ mediated gene changes taking place that result in renal cell carcinomas (RCC) in rat. Affymetrix microarray technology will be used to determine the gene dysregulation.

Publications:

  • Fisher, A.A., Labenski, M.T., Malladi, S., Chapman, J.D., Bratton, S.B., Monks, T.J. and Lau, S.S. The frequency of 1,4-benzoquinone-lysine adducts in cytochrome c correlate with defects in apoptosome activation, in press, 2011, Toxicol. Sci.
  • Fisher, A.A., Labenski, M.T., Monks, T.J., and Lau, S.S. Mass spectrometry-based methods to identify chemical modifications on proteins. I. Utilization of MALDI-TOF to determine chemical-protein adduct formation in vitro. In: Gautier, J.-C. (ed.). Drug Safety Evaluation Series - Methods of Molecular Medicine. Humana Press 2010; 303-16.
  • Fisher, A.A., Labenski, M.T., Monks, T.J, and Lau, S.S. Mass spectrometry-based methods to identify chemical modifications on proteins: II. Utilization of LC-MS/MS analyses to identify site-specific chemical protein adducts in vitro. In: Gautier, J.-C. (ed.). Drug Safety Evaluation Series - Methods in Molecular Medicine. Humana Press 2010; 317-26.
  • Labenski, M.T., Fisher, A.A., Monks, T.J., and Lau, S.S. Mass spectrometry-based methods to identify chemical modifications on proteins. III. one dimensional western blotting coupled to LC-MS/MS analysis to identify chemical-adducted proteins in urine. In: Gautier, J.-C. (ed.). Drug Safety Evaluation Series - Methods of Molecular Medicine. Humana Press 2010; 327-38.
  • Labenski, M.T., Fisher, A.A., Monks, T.J., and Lau, S.S. Mass spectrometry-based methods to identify chemical modifications on proteins. IV. Identification of chemical-adducted proteins in urine by multi-dimensional protein identification technology (LC/LC-MS/MS). In: Gautier, J.-C. (ed.). Drug Safety Evaluation Series - Methods of Molecular Medicine. Humana Press 2010; 339-50.
  • Labenski, M.T., Fisher, A.A., Lo, H.H., Monks, T.J. and Lau, S.S. Protein electrophile-binding motifs: lysine rich proteins are preferential targets of quinones. Drug Metab. and Disp., 37: 1211-1218, 2009.
  • Fisher, A.A., Labenski, M.T., Gokhale, V., Bowen, M.E., Milleron, R.S., Bratton, S.B., Monks, T. J. and Lau, S.S. Quinone electrophiles selectively adduct “electrophile binding motifs” within cytochrome c. Biochemistry, 46:11090-11100, 2007.

Past and present staff

Present Graduate Students

Ryan Canatsey | Owen Kinsky | Chris Kuhlman | Nick Mastrandrea | Jessica Sapiro | Kevin Xu


Present Postdoctoral Fellow
Tim Radabaugh

Research Associate

Alfred Gallegos

Clinical Faculty Mentee

Hussein Yassine

Current Undergraduate Students

Wesley Cai, Itzel Rojas, Audrey Shi, Kim Tham


Recent Past Staff

Martina Bowen | Jennifer Cohen | Ashley Fisher | Chris Hattan | Mike Kimzey | Matt Labenski | Jean Lord-Garcia

 

 

 

 

The University of Arizona | Pharmacy Home Page | Pharmacology and Toxicology Home Page
Southwest Environmental Health Sciences Center | BIO5 | Arizona Cancer Center
Graduate Training in Toxicology and Toxicogenomics | Human Gene and the Environment Research
National Institute of Environmental Health Sciences